Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Autologous 3rd generation CD19-targeting CAR T cells
Locations
1
Sweden
Uppsala University Hospital, Dept of Oncology
Uppsala, Sweden
Start Date
April 1, 2014
Primary Completion Date
May 31, 2017
Completion Date
May 31, 2017
Last Updated
October 30, 2017
NCT05006716
NCT06026319
NCT07368270
NCT07255963
NCT05940272
NCT06352242
Lead Sponsor
Uppsala University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions